Prognostic implications of serum microRNA-21 in colorectal cancer

Journal of Surgical Oncology

Volumn 108, Issue 6, 2013, Pages 369-373

  Menéndez, Pablo ^a   Padilla, David ^b   Villarejo, Pedro ^b   Palomino, Teodoro ^b   Nieto, Patricia ^b   Menéndez, José M ^c   Rodríguez Montes, José A ^d  

^a Hospital Gutierrez Ortega   (Spain)

^b Hospital General   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

colorectal cancer; diagnosis; microRNA; prognosis; serum

Indexed keywords

MICRORNA 21; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; SERUM; UNIVARIATE ANALYSIS;

EID: 84886799849     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23415     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Chang KH, Miller N, Kheirelseid EA, et al.: MicroRNA signature analysis in colorectal cancer: Identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 2011; 26: 1415-1422.
3. Wu CW, Ng SS, Dong YJ, et al.: Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012; 61: 739-745.
4. Mitchell PS, Parkin RK, Kroh EM, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
5. Schetter AJ, Harris CC:, Plasma microRNAs: A potential biomarker for colorectal cancer ? Gut 2009; 58: 1318-1319.
6. Menéndez P, Villarejo P, Padilla D, et al.: Diagnostic and prognostic significance of serum MicroRNAs in colorectal cancer. J Surg Oncol 2013; 107: 217-220.
7. Aslam MI, Taylor K, Pringle JH, et al.: MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009; 96: 702-710.
8. Nishida N, Yamashita S, Mimori K, et al.: MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann Surg Oncol 2012; 19: 3065-3071.
9. Wang B, Zhang Q:, The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 2012; 138: 1659-1666.
10. Livak KJ, Schmittgen TD:, Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 2001; 25: 402-408.
11. Cheng H, Zhang L, Cogdell DE, et al.: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 2011; 6: e17745.
12. Pu XX, Huang GL, Guo HQ, et al.: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010; 25: 1674-1680.
13. Wang ZX, Bian HB, Wang JR, et al.: Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011; 104: 847-851.
14. Liu GH, Zhou ZG, Ghen R, et al.: Serum niR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour Biol 2013; 34: 2175-2181.
15. Bangalore S, Messerli FH:, Of statistical significance: 'Trends' toward significance and optimism bias. J Am Coll Cardiol 2006; 48: 1471.
16. Xi Y, Shalgi R, Fodstad O, et al.: Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006; 12: 2014-2024.
17. Sayed D, Rane S, Lypowy J, et al.: MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 2008; 19: 3272-3282.
18. Slaby O, Svoboda M, Fabian P, et al.: Altered expression of miR-21, miR-31, miR-143m and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402.
19. Sabatel C, Malvaux L, Bovy N, et al.: MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS ONE 2011; 6: e16979.
20. Schetter AJ, Heegaard NH, Harris CC:, Inflammation and cancer interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31: 37-49.
21. Wang P, Zou F, Zhang X, et al.: microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009; 69: 8157-8165.
22. Brase JC, Wuttig D, Kuner R, et al.: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010; 9: 306.
23. Bihrer V, Waidmann O, Friedrich-Rust M, et al.: Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS ONE 2011; 6: e26971.
24. Ng EK, Chong WW, Jin H, et al.: Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
25. Huang Z, Huang D, Ni S, et al.: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-126.
26. Wang LG, Gu J:, Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 2012; 36: e61-e67.
27. Li C, Feng Y, Coukos G, et al.: Therapeutic microRNA strategies in human cancer. AAPS J 2009; 11: 747-757.
28. Kulda V, Pesta M, Topolcan O, et al.: Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 2010; 200: 154-160.